These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 21986212)
1. Neurological complications of acute intermittent porphyria. Kuo HC; Huang CC; Chu CC; Lee MJ; Chuang WL; Wu CL; Wu T; Ning HC; Liu CY Eur Neurol; 2011; 66(5):247-52. PubMed ID: 21986212 [TBL] [Abstract][Full Text] [Related]
2. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. Kauppinen R; von und zu Fraunberg M Clin Chem; 2002 Nov; 48(11):1891-900. PubMed ID: 12406973 [TBL] [Abstract][Full Text] [Related]
11. Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria. D'Avola D; López-Franco E; Sangro B; Pañeda A; Grossios N; Gil-Farina I; Benito A; Twisk J; Paz M; Ruiz J; Schmidt M; Petry H; Harper P; de Salamanca RE; Fontanellas A; Prieto J; González-Aseguinolaza G J Hepatol; 2016 Oct; 65(4):776-783. PubMed ID: 27212246 [TBL] [Abstract][Full Text] [Related]
12. Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse. Unzu C; Sampedro A; Sardh E; Mauleón I; Enríquez de Salamanca R; Prieto J; Salido E; Harper P; Fontanellas A PLoS One; 2012; 7(3):e32978. PubMed ID: 22412963 [TBL] [Abstract][Full Text] [Related]
13. Awareness is the name of the game: clinical and biochemical evaluation of a case of a girl diagnosed with acute intermittent porphyria associated with autism. Luder AS; Mamet R; Farbstein I; Schoenfeld N Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):19-22. PubMed ID: 19267997 [TBL] [Abstract][Full Text] [Related]
14. Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. Aarsand AK; Petersen PH; Sandberg S Clin Chem; 2006 Apr; 52(4):650-6. PubMed ID: 16595824 [TBL] [Abstract][Full Text] [Related]
15. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion. Floderus Y; Sardh E; Möller C; Andersson C; Rejkjaer L; Andersson DE; Harper P Clin Chem; 2006 Apr; 52(4):701-7. PubMed ID: 16497943 [TBL] [Abstract][Full Text] [Related]
16. Hepatocyte transplantation ameliorates the metabolic abnormality in a mouse model of acute intermittent porphyria. Yin Z; Wahlin S; Ellis EC; Harper P; Ericzon BG; Nowak G Cell Transplant; 2014; 23(9):1153-62. PubMed ID: 23582197 [TBL] [Abstract][Full Text] [Related]
17. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. Sardh E; Harper P; Andersson DE; Floderus Y Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613 [TBL] [Abstract][Full Text] [Related]